
Not long ago, nobody was talking about GLP-1 receptor agonists. Most of us did not even know what they were – natural hormones that regulate appetite, helping to reduce hunger and calorie intake. Today, GLP-1 drugs like semaglutide and tirzepatide are prescribed in their thousands and have altered global health.
This pharmaceutical success has sparked an intense obsession, triggering aggressive online marketing for “skinny pens” – self-injectable pens containing the medication.


